Global Point of Care

BinaxNOW™ COVID-19 Ag Card Home Test and NAVICA™ App

At-home, virtually guided COVID-19 antigen testing provides rapid and verifiable results in the safety and convenience of your home.

The 15-minute BinaxNOW™ COVID-19 Ag Card Home Test has received FDA Emergency Use Authorization for at-home testing in collaboration with eMed, a digital health solution. This first-of-its kind service for COVID-19 testing ships tests directly to your home and uses trained, virtual proctors to guide you through the test via video call. The complementary NAVICA™ mobile app to enables the testing process and displays BinaxNOW COVID-19 test results that are shareable at workplaces, organizations, or events that require proof of test for entry.

Prescription home use. Only available in the US.


Google Play and the Google Play Logo are trademarks of Google LLC.
App Store and the Apple Logo are trademarks of Apple Inc.

The BinaxNOW™ COVID-19 Ag Card Home Test has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization. The test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic  Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.